Molecular Oncology
Volume 2, Issue 3 , Pages 213-222 , October 2008

Biobanking for better healthcare

  • Peter H.J. Riegman

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center, Be 235b, Dr Molwaterplein 50, 3015 GE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Pathology, Josephine Nefkens Institute, Be 235b, Erasmus Medical Center, Dr Molwaterplein 50, 3015 GE Rotterdam, The Netherlands. Tel.: +31 107044421; fax: +31 107044762.
    web addressweb address
  • ,
  • Manuel M. Morente

      Affiliations

    • Centro Nacional de Investigaciones Oncologicas, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
  • ,
  • Fay Betsou

      Affiliations

    • Biobanque de Picardie, Centre Hospitalier Universitaire d'Amiens, avenue René Laënnec, 80480 Salouel, France
  • ,
  • Pasquale de Blasio

      Affiliations

    • BioRep srl, Via Fantoli 16/15, 20138 Milano, Italy
  • ,
  • Peter Geary

      Affiliations

    • Canadian Tumour Repository Network, 675 McDermot Avenue, Rm. ON 6022 Winnipeg, Manitoba R3E OV9, Canada
  • ,
  • the Marble Arch International Working Group on Biobanking for Biomedical Research

      Affiliations

    • Marble Arch Working group members: Fay Betsou, Biobanque de Picardie, Centre Hospitalier Universitaire d'Amiens, Salouel, France; Roger Bjugn, Ullevaal University Hospital, Oslo, Norway; Brian Clark, Oncore UK, Hertfordshire, UK; Johan Botling, Department of Genetics and Pathology, Uppsala, Sweden; Pasquale Deblasio, Biorep S.r.l., Milan, Italy; Mylene Deschenes, P3G Consortium, Montreal, Quebec, Canada; Rajiv Dhirr, Department of Pathology, University of Pittsburgh School of Medicine, PA, USA; Ian Fore, Biorepository and Pathology Informatics, NCI Center for Bioinformatics, Rockville, USA; Eoin Gaffney, Consultant Histopathologist, Department of Histopathology, St. James's Hospital, Dublin, Ireland; Peter Geary, Canadian Tumour Repository Network, Winnipeg, Manitoba, Canada; Peter Goebell Universitätsklinikum Erlangen, Erlangen, Germany.William Grizzle, Tissue Collection & Banking Facility, University of Alabama, Birmingham, USA; Pierre Hainaut, International Agency for Research on Cancer, IARC, Lyon, France; Jane Hair, Bio Bank Services, Pathology Department Glasgow Royal Infirmary, Glasgow, UK; Robert Hewitt, NUH-NUS Tissue Repository, National University Hospital, Singapore; Karen Meir, Department of Pathology, Hadassah University Hospital, Jerusalem, Israel; Anne-Marie Mes-Masson, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada; Lisa Miranda, University of Pennsylvania, Haddon Township, USA; Manuel Morente, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain; Alison Parry-Jones Wales Cancer Bank, Cardiff, UK.Alexandre Passioukov EORTC Data Center, Brussels, Belgium; Peter Riegman, Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center, Rotterdam, The Netherlands; Jose Claudio Casali Da Rocha, Brazilian National Tumor Bank, Instituto Nacional de Cancer, Rio de Janeiro, Brazil; Daniel Simeon-Dubach Foundation Biobank-Suisse, Bern, Switzerland; Fernando Soares, A C Camargo Biobank, Hospital A C Camargo, Sao Paulo, Brazil; Gerry Thomas, Wales Cancer Bank, Cardiff, UK; Jim Vaught, Office of Biorepositories & Biospecimen Research, NCI/OD, Bethesda, USA; Nikolajs Zeps, Radiation Oncology, Sir Charles Gaidner Hospital, Perth, Australia.

Received 15 July 2008 ,Revised 18 July 2008 ,Accepted 21 July 2008.

References 

  1. Almeida A, Thiery JP, Magdele´nat H, Radvanyi F. Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling. Anal. Biochem. 2004;328:101–108
  2. Betsou, F., Luzergues, A., Carter, A., Geary, P., Riegman, P., Clark, B., Morente, M., Vaught, J., Dhirr, R., Druez-Vérité, C., and the Marble Arch Working Group on International Biobanking. Towards norms for accreditation of biobanks for human health and medical research: compilation of existing guidelines into an ISO certification/accreditation norm-compatible format. The Quality Assurance Journal, in press.
  3. Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, et al. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia. 2004;6:761–767
  4. In:  Caboux E,  Plymoth A,  Hainaut P editor. International Network of Biological Resource Centres for Cancer Research: Recommendations on Common Minimal Technical Standards. Lyon: IARC/WHO; 2007;Available from: http://www.iarc.fr/IARCPress/pdfs/standardsBRC/Standards_ProtocolsBRC.pdf
  5. Chaigneau C, Cabioch T, Beaumont K, Betsou F. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation. Clin. Chem. Lab. Med. 2007;45:1390–1395
  6. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur. Respir. J. 2007;30:373–382
  7. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am. J. Pathol. 2002;161:1743–1748
  8. van Diese PJ. No consent should be needed for using leftover body material for scientific purposes. Br. Med. J. 2002;325:648–650
  9. Grizzle WE, Aamodt R, Clausen K, LiVolsi V, Pretlow TG, Qualman S. Providing human tissues for research: how to establish a program. Arch. Pathol. Lab. Med. 1998;122:1065–1076
  10. Hansson MG. For the safety and benefit of current and future patients. Pathobiology. 2007;74:198–205
  11. Helgesson G, Dillner J, Carlson J, Bartram CR, Hansson MG. Ethical framework for previously collected biobank simples. Nat. Biotechnol. 2007;25:973–976
  12. Homan R. The principle of assumed consent: the ethics of gatekeeping. J. Philos. Educ. 2001;35:329–343
  13. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression. J. Surg. Res. 2001;99:222–227
  14. International Society for Biological and Environmental Repositories (ISBER) . Best practices for repositories: collection, storage, retrieval and distribution of biological materials for research. Available from: Cell Preserv. Technol. 2008;6:3–58http://www.isber.org/Pubs/BestPractices2008.pdf
  15. Jackson D, Rowlinnson RA, Eaton CK, Nickson JA, Wilson ID, Mills JD, et al. Prostatic tissue protein alterations due to delayed time to freezing. Proteomics. 2006;6:3901–3908
  16. Lunshof JE, Chadwick R, Vorhaus DB, Church GM. From genetic privacy to open consent. Nat. Rev. Genet. 2008;9:406–411
  17. Langellé, J., Panopoulos, E., Betsou, F. Soluble CD40-ligand as a biomarker for storage-related pre-analytic variations of human serum cytokine, submitted for publication.
  18. Mager SR, Oomen MH, Morente MM, Ratcliffe C, Knox K, Kerr DJ, et al. Standard operating procedure for the collection of fresh frozen tissue samples. Eur. J. Cancer. 2007;43:828–834
  19. Maschke KJ. Alternative consent approaches for biobank research. Lancet Oncol. 2006;7:193–194
  20. Micke P, Ohshima M, Tahmasebpoor S, Ren ZP, Ostman A, Pontén F, et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab. Invest. 2006;86:202–211
  21. Morente MM, de Alava E, Fernandez PL. Tumour banking: the Spanish design. Pathobiology. 2007;74:245–250
  22. Morente MM, Mager R, Alonso S, Pezzella F, Spatz A, Knox K, et al. TuBaFrost 2: standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur. J. Cancer. 2006;42:2684–2691
  23. NCI . NCI Best Practices for Specimen Resources. Bethesda: NCI; 2007;Available from: http://biospecimens.cancer.gov/global/pdfs/NCI_Best_Practices_060507.pdf
  24. In: OECD  editors. OECD Best Practice Guidelines for Biological Resource Centers – General Best Practice Guidelines for all BRCs. Paris: OECD; 2007;Available from: http://www.oecd.org/dataoecd/7/13/38777417.pdf
  25. In: OECD  editors. Biological Resource Centres: Underpinning the Future of Life Sciences and Biotechnology. Paris: OECD; 2001;Available from: http://www.oecd.org/dataoecd/55/48/2487422.pdf
  26. Oosterhuis JW, Coebergh JW, van Veen EB. Tumour banks: well-guarded treasures in the interest of patients. Nat. Rev. Cancer. 2003;3:73–77
  27. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics. 2005;5:3262–3277
  28. Riegman PH, Llombart-Bosch A. OECI TuBaFrost Consortium. OECI TuBaFrost tumor biobanking. Tumori. 2008;94:160–163
  29. Riegman PH, Dinjens WN, Oosterhuis JW. Biobanking for interdisciplinary clinical research. Pathobiology. 2007;74:239–244
  30. Riegman PH, Dinjens WN, Oomen MH, Spatz A, Ratcliffe C, Knox K, et al. TuBaFrost 1: uniting local frozen tumor banks into a European network, an overview. Eur. J. Cancer. 2006;42:2678–2683
  31. Salvaterra E, Lecchi L, Giovanelli S, Butti B, Bardella MT, Bertazzi PA, et al. Banking together: a unified model of informed consent for biobanking. EMBO Rep. 2008;9:307–313
  32. Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, et al. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumour excision. Biotechniques. 2004;36:1030–1037
  33. van Veen EB, Riegman PH, Dinjens WN, Lam KH, Oomen MH, Spatz A, et al. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur. J. Cancer. 2006;42:2914–2923
  34. Wendler D. One-time general consent for research on biological samples. Br. Med. J. 2006;332:544–547
  35. Yuille M, van Ommen GJ, Bréchot C, Cambon-Thomsen A, Dagher G, Landegren U, et al. Biobanking for Europe. Brief. Bioinform. 2008;9:14–24
  36. Zimmerman LJ, Wernke GB, Caprioli RM, Liebler DC. Identification of protein fragments as pattern features in MALDI-MS analyses of serum. J. Proteome Res. 2005;4:1672–1680

PII: S1574-7891(08)00094-X

doi: 10.1016/j.molonc.2008.07.004

Molecular Oncology
Volume 2, Issue 3 , Pages 213-222 , October 2008